Siirry sisältöön
Optomed
  • About us
    • Column1
    • Optomed’s story
    • Research and Development
    • IPR
    • Corporate Responsibility
    • News and events
    • Careers
    • Management
  • Products & Solutions
    • Column1
    • HANDHELD CAMERAS
    • Optomed Aurora IQ
    • Smartscope PRO
    • VET
    • Optomed E-Safe
    • DESKTOP CAMERAS
    • Optomed Polaris
    • Optomed Halo
    • Column2
    • NEUROLOGY
    • SOLUTIONS
    • Ophthalmology
    • Avenue SaaS
    • Avenue AI
    • Avenue Eye Screen
    • Avenue Telemedicine
    • Avenue Archive
    • Avenue Sync
    • Avenue Flow
    • Hidden item
    • Cancer Screening
    • Avenue Cancer Screen
    • Radiology
    • Optomed Radiology Information System (RIS)
    • Sectra PACS
    • Optomed Service Portal
    • Cephalometry
    • Pathology
    • Sectra PACS Pathology
  • Customers
    • Column1
    • References
    • Clinical studies
    • Scientific Advisory Board
  • Investors
    • Column1
    • OPTOMED AS AN INVESTMENT
    • Key figures
    • Business model
    • Markets
    • Strategy
    • Mission and values
    • Future outlook
    • Financial targets and dividend policy
    • Corporate Responsibility
    • INVESTOR RELATIONS
    • Column2
    • RELEASES AND PUBLICATIONS
    • Annual reports
    • Financial reports and presentations
    • Interviews
    • ANALYSTS
    • Column3
    • SHARES AND SHAREHOLDERS
    • Management transactions
    • Shareholders
    • Share monitor
    • Flagging notifications
    • Option Programs
    • Authorizations
    • IR CALENDAR
    • Investor events
    • Column4
    • CORPORATE GOVERNANCE
    • General Meeting
    • Previous General Meetings
    • Statements and Reports
    • Articles of association
    • Board of Directors
    • Committees
    • Shareholders’ Nomination Board
    • CEO and Leadership Team
    • Remuneration
    • Risk management
    • Insider management
    • External Auditor
    • Disclosure policy
    • Related party transactions
    • Whistleblowing instructions
    • IPO 2019
  • Contact
    • Column1
    • Where to buy
    • Support
    • Media
  • About us
    • Column1
    • Optomed’s story
    • Research and Development
    • IPR
    • Corporate Responsibility
    • News and events
    • Careers
    • Management
  • Products & Solutions
    • Column1
    • HANDHELD CAMERAS
    • Optomed Aurora IQ
    • Smartscope PRO
    • VET
    • Optomed E-Safe
    • DESKTOP CAMERAS
    • Optomed Polaris
    • Optomed Halo
    • NEUROLOGY
    • SOLUTIONS
    • Ophthalmology
    • Avenue SaaS
    • Avenue AI
    • Avenue Eye Screen
    • Avenue Telemedicine
    • Avenue Archive
    • Avenue Sync
    • Avenue Flow
    • Hidden item
    • Cancer Screening
    • Avenue Cancer Screen
    • Radiology
    • Optomed Radiology Information System (RIS)
    • Sectra PACS
    • Optomed Service Portal
    • Cephalometry
    • Pathology
    • Sectra PACS Pathology
  • Customers
    • Column1
    • References
    • Clinical studies
    • Scientific Advisory Board
  • Investors
    • Column1
    • OPTOMED AS AN INVESTMENT
    • Key figures
    • Business model
    • Markets
    • Strategy
    • Mission and values
    • Future outlook
    • Financial targets and dividend policy
    • Corporate Responsibility
    • INVESTOR RELATIONS
    • Column2
    • RELEASES AND PUBLICATIONS
    • Annual reports
    • Financial reports and presentations
    • Interviews
    • ANALYSTS
    • Column3
    • SHARES AND SHAREHOLDERS
    • Management transactions
    • Shareholders
    • Share monitor
    • Flagging notifications
    • Option Programs
    • Authorizations
    • IR CALENDAR
    • Investor events
    • Column4
    • CORPORATE GOVERNANCE
    • General Meeting
    • Previous General Meetings
    • Statements and Reports
    • Articles of association
    • Board of Directors
    • Committees
    • Shareholders’ Nomination Board
    • CEO and Leadership Team
    • Remuneration
    • Risk management
    • Insider management
    • External Auditor
    • Disclosure policy
    • Related party transactions
    • Whistleblowing instructions
    • IPO 2019
  • Contact
    • Column1
    • Where to buy
    • Support
    • Media
Optomed | Interim Report for 1 January – 31 March 2024

Interim Report for 1 January – 31 March 2024

4.8.2023
Back
Jaa Facebookissa Jaa Twitterissä Jaa LinkedInissä Jaa WhatsAppissa
Support Contact Privacy statement
  • FacebookFacebook
  • TwitterTwitter
  • YouTubeYouTube
  • LinkedInLinkedIn

Optomed is a Valued Supplier on the IAPB Standard List

 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

Our camera products have medical approvals in all key markets, including CE (Europe) and FDA (USA), and CFDA (China).

We use cookies for analytics to improve your experience with us. To find out more, have a look at our Privacy Policy and Cookie Policy. If you decline, your information won't be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked. Accept AllCustomize
Privacy & Cookies Policy

Privacy Overview

We use cookies for analytics to improve your experience with us. To find out more, have a look at our Privacy Policy. If you decline, your information won't be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Save & Accept